Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Healthcare Cannabis
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol... see more

Recent & Breaking News (NDAQ:TLRY)

Booming European CBD Sales Signal a New Potentially Multi-Billion-Dollar Market

Press Releases May 30, 2019

Tilray® Boosts International Export Capacity with Manufacturing License and GMP Certification at EU Campus

Business Wire May 23, 2019

Tilray, Inc. Reports First Quarter 2019 Financial Results

Business Wire May 14, 2019

Aurora/ EnWave Deal Shows Investors Why Being Dry is a High Priority-THC Therapeutics, Inc.

Press Releases May 8, 2019

Tilray® Announces Investment to Expand Canadian Production and Manufacturing Footprint to Increase Supply of Medical and Adult-Use Cannabis

Business Wire May 8, 2019

Tilray, Inc. to Present at the BMO Farm to Market Conference

Business Wire May 3, 2019

High Park(TM) Expands Supply Capacity with Sale License from Health Canada

Business Wire April 29, 2019

Tilray® Hosts Official Ribbon-Cutting Ceremony at European Union Campus for Medical Cannabis Production and Distribution

Business Wire April 24, 2019

Tilray to Report First Quarter 2019 Financial Results on May 14, 2019

Business Wire April 23, 2019

How One Cannabis Company Is Quadrupling Their Production Footprint in 2019

Press Releases April 18, 2019

A True Canadian Cannabis Retail Brand

Jonathon Brown April 9, 2019

Tilray Announces Support Of 2 Clinical Studies In Australia, Canada

Benzinga.com  April 1, 2019

5 Companies Prepared to Dominate U.S. Hemp-infused Beverages

GlobeNewswire April 1, 2019

The Top 5 Cannabis Retail Brands in Canada

GlobeNewswire April 1, 2019

Tilray® Announces Support of Two New Clinical Research Studies in Australia and Canada

Business Wire April 1, 2019

Tilray® Expands Manufacturing Capacity with New Processing License from Health Canada

Business Wire March 29, 2019

CannTrust Posts Record Q4 Revenue, But Falls Short Of Expectations

Benzinga.com  March 28, 2019

Tilray’s Christine St.Clare Named Among the Most Influential Corporate Directors in the U.S.

Business Wire March 26, 2019

Thinking about buying stock in Altimmune Inc., Dare Bioscience Inc., Phasebio Pharmaceuticals Inc., Stoneco Ltd., or Tilray Inc.?

PR Newswire March 19, 2019

Tilray, Inc. Reports Full Year 2018 Financial Results

Business Wire March 18, 2019